semaglutide Archives -

Novo’s new oral GLP-1 Rybelsus still has obstacles to overcome

https://pharmaphorum.com/news/novos-new-oral-glp-1-still-has-obstacles-to-overcome/

Gilead and Novo Nordisk collaborate for NASH trial

https://pharmaphorum.com/news/gilead-and-novo-nordisk-collaborate-for-nash-trial/

Novo’s oral semaglutide on target in phase 3 trial

https://pharmaphorum.com/news/novos-oral-semaglutide-target-phase-3-trial/

Novo’s diabetes pill beats injections in head-to-head trials

https://pharmaphorum.com/news/novo-nordisks-success-with-oral-diabetes-drug/

FDA experts back Novo Nordisk’s key diabetes drug

https://pharmaphorum.com/news/fda-experts-back-novo-nordisks-semaglutide/

No cardio protection indication for Novo’s semaglutide – yet

https://pharmaphorum.com/news/no-cardio-protection-label-novos-semaglutide-yet/

PureTech’s device could rival Saxenda in obesity market

https://pharmaphorum.com/news/puretech-aims-weight-loss-market-gelesis100/

Novo’s semaglutide outperforms Lilly GLP-1 rival

https://pharmaphorum.com/news/semaglutide-outperforms-lilly-glp-1-rival/

Semaglutide could transform diabetes treatment, revive Novo Nordisk revenues

https://pharmaphorum.com/news/semaglutide-transform-diabetes-treatment-revive-novo-nordisk-revenues/

Search